Skip to main content
Clinical Trials/ACTRN12607000356460
ACTRN12607000356460
Completed
Not Applicable

The split thickness skin graft donor site; A prospective randomised controlled trial that demonstrates improved rates of healing, reduced pain and superior ease of management with Tegaderm Absorbent in comparision to Kaltostat aliginate dressings.

Patricia terrill0 sites40 target enrollmentJuly 3, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Split thickness skin graft donor sites
Sponsor
Patricia terrill
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 3, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Patricia terrill

Eligibility Criteria

Inclusion Criteria

  • All patients requiring a split thickness skin graft to be harvested from their thigh

Exclusion Criteria

  • Patients with allergies to Polyurethrane film dressings or Mefix tape.

Outcomes

Primary Outcomes

Not specified

Similar Trials